Cargando…
Bailing Capsule combined with α-ketoacid tablets for stage 3 chronic kidney disease: Protocol of a double-blinded, randomized, controlled trial
BACKGROUND: Chronic kidney disease (CKD) is a progressive and irreversible loss of kidney function. After stage 3, there will be increased risks of hypertension, heart failure, bone disease, anemia, gastrointestinal symptoms, and progression to end-stage kidney failure without proper intervention an...
Autores principales: | Hu, Xiuhong, Wang, Jing, Yang, Hongjuan, Ji, Suhua, Li, Yuhong, Xu, Baozhen, Cui, Hongrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136994/ https://www.ncbi.nlm.nih.gov/pubmed/34011035 http://dx.doi.org/10.1097/MD.0000000000025759 |
Ejemplares similares
-
Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy: A protocol for a parallel, randomized, double-blind, controlled clinical trial
por: Jiao, Shengfu, et al.
Publicado: (2022) -
Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study
por: Poulin, Aurélie, et al.
Publicado: (2017) -
Clinical observation on the effect of Wuzhi soft capsule on FK506 concentration in membranous nephropathy patients
por: Zhang, Zhu, et al.
Publicado: (2019) -
Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation
por: Gao, Ying, et al.
Publicado: (2021) -
Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients
por: Steubl, Dominik, et al.
Publicado: (2016)